Advertisement
Screener

Autolus Therapeutics plc (AUTL) Market Cap

Autolus Therapeutics plc (AUTL) Market Cap

  • 2026-09-03: Market Cap $609.51M.
  • 2026-08-10: Market Cap $550.96M.
  • 2026-05-13: Market Cap $455.13M.
  • 2026-03-26: Market Cap $343.32M.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2018-09-30 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$609.51M
2026-08-10$550.96M
2026-05-13$455.13M
2026-03-26$343.32M
2025-11-11$399.21M
2025-08-11$657.37M
2025-05-07$327.35M
2025-03-19$516.29M
2024-11-08$992.63M
2024-08-06$1.04B
2024-05-13$1.07B
2024-03-20$1.74B
2023-11-09$607.22M
2022-12-31$328.84M
2021-12-31$471.81M
2020-12-31$467.98M
2019-12-31$593.78M
2018-12-31$1.32B
2018-09-30$1.23B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56